騰訊(00700.HK):中國疫情影響料下半年廣告業務復甦受阻
騰訊(00700.HK)首席戰略官James Mitchell表示,中國疫情持續,在線廣告業務下半年料將繼續受到影響,業務復甦時間或有變動,亦令娛樂應用增長較緩慢,但同時推動騰訊會議等工作應用拓展速度較快。
他又透露,內地當局重新啓動遊戲版號審批,對本土遊戲業務有正面作用,有利發行更多遊戲產品,同時亦反映監管機構滿意行業現況,預期行業發展將會改善。雖然首批獲批新遊戲未有騰訊的產品,但相信接下來騰訊等較大公司都將獲批版號,明年亦會在國際市場推出更多高投入的遊戲。但整體而言,未來獲批的遊戲數量將會減少。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.